Skip to main content
Top
Published in: Medical Gas Research 1/2011

Open Access 01-12-2011 | Review

Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?

Authors: Masaru Sagai, Velio Bocci

Published in: Medical Gas Research | Issue 1/2011

Login to get access

Abstract

The potential mechanisms of action of ozone therapy are reviewed in this paper. The therapeutic efficacy of ozone therapy may be partly due the controlled and moderate oxidative stress produced by the reactions of ozone with several biological components. The line between effectiveness and toxicity of ozone may be dependent on the strength of the oxidative stress. As with exercise, it is well known that moderate exercise is good for health, whereas excessive exercise is not.
Severe oxidative stress activates nuclear transcriptional factor kappa B (NFκB), resulting in an inflammatory response and tissue injury via the production of COX2, PGE2, and cytokines. However, moderate oxidative stress activates another nuclear transcriptional factor, nuclear factor-erythroid 2-related factor 2 (Nrf2). Nrf2 then induces the transcription of antioxidant response elements (ARE). Transcription of ARE results in the production of numerous antioxidant enzymes, such as SOD, GPx, glutathione-s-transferase(GSTr), catalase (CAT), heme-oxygenase-1 (HO-1), NADPH-quinone-oxidoreductase (NQO-1), phase II enzymes of drug metabolism and heat shock proteins (HSP). Both free antioxidants and anti-oxidative enzymes not only protect cells from oxidation and inflammation but they may be able to reverse the chronic oxidative stress. Based on these observations, ozone therapy may also activate Nrf2 via moderate oxidative stress, and suppress NFκB and inflammatory responses. Furthermore, activation of Nrf2 results in protection against neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Mild immune responses are induced via other nuclear transcriptional factors, such as nuclear factor of activated T-cells (NFAT) and activated protein-1 (AP-1).
Additionally, the effectiveness of ozone therapy in vascular diseases may also be explained by the activation of another nuclear transcriptional factor, hypoxia inducible factor-1α (HIF-1a), which is also induced via moderate oxidative stress. Recently these concepts have become widely accepted. The versatility of ozone in treating vascular and degenerative diseases as well as skin lesions, hernial disc and primary root carious lesions in children is emphasized. Further researches able to elucidate whether the mechanisms of action of ozone therapy involve nuclear transcription factors, such as Nrf2, NFAT, AP-1, and HIF-1α are warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolff HH: Die Behandlung peripherer Durchbutungsstorungen mit Ozon. Erfahr Hk. 1974, 23: 181-184. Wolff HH: Die Behandlung peripherer Durchbutungsstorungen mit Ozon. Erfahr Hk. 1974, 23: 181-184.
2.
3.
go back to reference Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991, 43: 109-142.PubMed Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991, 43: 109-142.PubMed
4.
go back to reference Morse D, Sethi J, Choi AM: Carbon monoxide-dependent signaling. Crit Care Med. 2002, 30: S12-17.PubMed Morse D, Sethi J, Choi AM: Carbon monoxide-dependent signaling. Crit Care Med. 2002, 30: S12-17.PubMed
5.
go back to reference Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ: Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009, 105: 365-374.PubMedCentralPubMed Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ: Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009, 105: 365-374.PubMedCentralPubMed
6.
go back to reference Xu ZS, Wang XY, Xiao DM, Hu LF, Lu M, Wu ZY, Bian JS: Hydrogen sulfide protects MC3T3-E-1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis. Free Radic Biol Med. 2011, 50: 1314-1323.PubMed Xu ZS, Wang XY, Xiao DM, Hu LF, Lu M, Wu ZY, Bian JS: Hydrogen sulfide protects MC3T3-E-1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis. Free Radic Biol Med. 2011, 50: 1314-1323.PubMed
7.
go back to reference Jolly D, Meyer J: A brief review of radiation hormesis. Australas Phys Eng Sci Med. 2009, 32: 180-187.PubMed Jolly D, Meyer J: A brief review of radiation hormesis. Australas Phys Eng Sci Med. 2009, 32: 180-187.PubMed
8.
go back to reference Calabrese EJ: Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol. 2010, 29: 249-61.PubMed Calabrese EJ: Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol. 2010, 29: 249-61.PubMed
9.
go back to reference Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009, 325: 201-204.PubMedCentralPubMed Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009, 325: 201-204.PubMedCentralPubMed
10.
go back to reference Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA: Caloric restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004, 305: 390-392.PubMed Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA: Caloric restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004, 305: 390-392.PubMed
11.
go back to reference Pryor WA, Squadrito GL, Friedman M: The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med. 1995, 19: 935-941.PubMed Pryor WA, Squadrito GL, Friedman M: The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med. 1995, 19: 935-941.PubMed
12.
go back to reference Shimasaki H, Takatori T, Anderson WR, Horten HL, Privett OS: Alteration of lung lipids in ozone exposed rats. Biochem Biophys Res Commun. 1976, 68: 1256-1262.PubMed Shimasaki H, Takatori T, Anderson WR, Horten HL, Privett OS: Alteration of lung lipids in ozone exposed rats. Biochem Biophys Res Commun. 1976, 68: 1256-1262.PubMed
13.
go back to reference Dianzani MUl: 4-Hydroxynonenal and cell signaling. Free Radi Res. 1998, 28: 553-560. Dianzani MUl: 4-Hydroxynonenal and cell signaling. Free Radi Res. 1998, 28: 553-560.
14.
go back to reference Page S, Fischer C, Baumqartner B, Haas M, Kreusel U, Loidl G, Hayn M, Ziegler-Heitbrock HW, Neumeier D, Brand K: 4-Hydroxynonenal prevents NFκB activation and tumor necrosis factor expression by inhibiting IκB phosphorylation and subsequent proteolysis. J Biol Chem. 1999, 274: 11611-11618.PubMed Page S, Fischer C, Baumqartner B, Haas M, Kreusel U, Loidl G, Hayn M, Ziegler-Heitbrock HW, Neumeier D, Brand K: 4-Hydroxynonenal prevents NFκB activation and tumor necrosis factor expression by inhibiting IκB phosphorylation and subsequent proteolysis. J Biol Chem. 1999, 274: 11611-11618.PubMed
15.
go back to reference Groeger G, Quiney C, Cotter TG: Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal. 2009, 11: 2655-2671.PubMed Groeger G, Quiney C, Cotter TG: Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal. 2009, 11: 2655-2671.PubMed
16.
go back to reference Hao Q, Rutherford SA, Low B, Tang H: Selective regulation of hydrogen peroxide signaling by receptor tyrosine phosphatase-alpha. Free Radic Biol Med. 2006, 41: 302-310.PubMed Hao Q, Rutherford SA, Low B, Tang H: Selective regulation of hydrogen peroxide signaling by receptor tyrosine phosphatase-alpha. Free Radic Biol Med. 2006, 41: 302-310.PubMed
17.
go back to reference Lin CC, Lee IT, Yang YL, Lee CW, Kou YR, Yang CM: Induction of COX-2/PGE2/IL-6 is crucial for cigarette smoke extract-induced airway inflammation: role of TLR4 -dependent NADPH oxidase activation. Free Radic Biol Med. 2010, 48: 240-254.PubMed Lin CC, Lee IT, Yang YL, Lee CW, Kou YR, Yang CM: Induction of COX-2/PGE2/IL-6 is crucial for cigarette smoke extract-induced airway inflammation: role of TLR4 -dependent NADPH oxidase activation. Free Radic Biol Med. 2010, 48: 240-254.PubMed
18.
go back to reference Williams AS, Leung SY, Nath P, Khorasani NM, Bhavsar P, Issa R, Mitchell JA, Adcock IM, Chung KF: Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol. 2007, 103: 1189-1195.PubMed Williams AS, Leung SY, Nath P, Khorasani NM, Bhavsar P, Issa R, Mitchell JA, Adcock IM, Chung KF: Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol. 2007, 103: 1189-1195.PubMed
19.
go back to reference Lippman M: Health effects of ozone, a critical review. J Am Air Pollut Control Assoc. 1989, 39: 672-695. Lippman M: Health effects of ozone, a critical review. J Am Air Pollut Control Assoc. 1989, 39: 672-695.
20.
go back to reference Bhalla DK, Gupta SK: Lung injury, inflammation, and inflammatory stimuli in rats exposed to ozone. J Toxicol Environ Health. 2000, 59: 211-228. Bhalla DK, Gupta SK: Lung injury, inflammation, and inflammatory stimuli in rats exposed to ozone. J Toxicol Environ Health. 2000, 59: 211-228.
21.
go back to reference Jerrett M, Burnett RT, Pope CA, Ito K, Thurston G, Krewski D, Shi Y, Calle E, Thun M: Long-term ozone exposure and mortality. N Engl J Med. 2009, 360: 1085-1095.PubMedCentralPubMed Jerrett M, Burnett RT, Pope CA, Ito K, Thurston G, Krewski D, Shi Y, Calle E, Thun M: Long-term ozone exposure and mortality. N Engl J Med. 2009, 360: 1085-1095.PubMedCentralPubMed
22.
go back to reference Valacchi G, Pagnin E, Corbacho AM, Olano E, Davis PA, Packer L, Cross CE: In vivo ozone exposure induces antioxidant/stress-related responses in murine lungs and skin. Free Radic Biol Med. 2004, 36: 673-681.PubMed Valacchi G, Pagnin E, Corbacho AM, Olano E, Davis PA, Packer L, Cross CE: In vivo ozone exposure induces antioxidant/stress-related responses in murine lungs and skin. Free Radic Biol Med. 2004, 36: 673-681.PubMed
23.
go back to reference Valacchi G, Fortino V, Bocci V: The dual action of ozone on the skin. Br J Dermatol. 2005, 153: 1096-1100.PubMed Valacchi G, Fortino V, Bocci V: The dual action of ozone on the skin. Br J Dermatol. 2005, 153: 1096-1100.PubMed
24.
go back to reference Wentworth P, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T, Bautista C, Ruedi JM, Gutierrez A, Janda KD, Babior BM, Eschenmoser A, Lerner RA: Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. 2002, 298: 2195-99.PubMed Wentworth P, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T, Bautista C, Ruedi JM, Gutierrez A, Janda KD, Babior BM, Eschenmoser A, Lerner RA: Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. 2002, 298: 2195-99.PubMed
25.
go back to reference Yamashita K, Miyoshi T, Arai T, Endo N, Itoh H, Makino K, Mizugishi K, Uchiyama T, Sasada M: Ozone production by amino acids contributes to killing of bacteria. Proc Natl Acad Sci, USA. 2008, 105: 16912-7.PubMedCentralPubMed Yamashita K, Miyoshi T, Arai T, Endo N, Itoh H, Makino K, Mizugishi K, Uchiyama T, Sasada M: Ozone production by amino acids contributes to killing of bacteria. Proc Natl Acad Sci, USA. 2008, 105: 16912-7.PubMedCentralPubMed
26.
go back to reference Bastacky J, Lee CY, Goerke J, Koushafar H, Yager D, Kenaga L, Speed TP, Chen Y, Clements JA: Alveolar lining layer is thin and continuous: low temperature scanning electron microscopy of rat lung. J Appl Physiol. 1995, 79: 1615-1628.PubMed Bastacky J, Lee CY, Goerke J, Koushafar H, Yager D, Kenaga L, Speed TP, Chen Y, Clements JA: Alveolar lining layer is thin and continuous: low temperature scanning electron microscopy of rat lung. J Appl Physiol. 1995, 79: 1615-1628.PubMed
27.
go back to reference Mustafa MG: Biochemical basis of ozone toxicity. Free Radic Biol Med. 1990, 9: 245-265.PubMed Mustafa MG: Biochemical basis of ozone toxicity. Free Radic Biol Med. 1990, 9: 245-265.PubMed
28.
go back to reference Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991, 11: 81-128.PubMed Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991, 11: 81-128.PubMed
29.
go back to reference Schaur RJ: Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med. 2003, 24: 149-159.PubMed Schaur RJ: Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med. 2003, 24: 149-159.PubMed
30.
go back to reference Pulfer MK, Taube C, Gelfand E, Murphy RC: Ozone exposure in vivo and formation of biologically active oxysterols in the lung. J Pharmacol Exp Ther. 2005, 312: 256-264.PubMed Pulfer MK, Taube C, Gelfand E, Murphy RC: Ozone exposure in vivo and formation of biologically active oxysterols in the lung. J Pharmacol Exp Ther. 2005, 312: 256-264.PubMed
31.
go back to reference Sathishkumar K, Haque M, Perumal TE, Francis J, Uppu RM: A major ozonation product of cholesterol, 3-beta-hydroxy-5-oxo-5,6-secocholestan- 6-al, induces apoptosis in H9c2 cardiomyoblasts. FEBS Lett. 2005, 579: 6444-6450.PubMed Sathishkumar K, Haque M, Perumal TE, Francis J, Uppu RM: A major ozonation product of cholesterol, 3-beta-hydroxy-5-oxo-5,6-secocholestan- 6-al, induces apoptosis in H9c2 cardiomyoblasts. FEBS Lett. 2005, 579: 6444-6450.PubMed
32.
go back to reference Mendiratta S, Qu ZC, May JM: Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med. 1998, 24: 789-797.PubMed Mendiratta S, Qu ZC, May JM: Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med. 1998, 24: 789-797.PubMed
33.
go back to reference Crapo JD: Morphologic changes in pulmonary oxygen toxicity. Ann Rev Physiol. 1986, 48: 721-731. Crapo JD: Morphologic changes in pulmonary oxygen toxicity. Ann Rev Physiol. 1986, 48: 721-731.
34.
go back to reference Ruidavets JB, Cournot M, Cassadou S, Giroux M, Meybeck M, Ferrieres J: Ozone air pollution is associated with acute myocardial infarction. Circulation. 2005, 111: 563-569.PubMed Ruidavets JB, Cournot M, Cassadou S, Giroux M, Meybeck M, Ferrieres J: Ozone air pollution is associated with acute myocardial infarction. Circulation. 2005, 111: 563-569.PubMed
35.
go back to reference Tager IB, Balmes J, Lurmann F, Ngo L, Alcorn S, Kunzli N: Chronic exposure to ambient ozone and lung function in young adults. Epidemiology. 2005, 16: 751-759.PubMed Tager IB, Balmes J, Lurmann F, Ngo L, Alcorn S, Kunzli N: Chronic exposure to ambient ozone and lung function in young adults. Epidemiology. 2005, 16: 751-759.PubMed
36.
go back to reference Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR: Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis. 1993, 148: 1363-1372.PubMed Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR: Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis. 1993, 148: 1363-1372.PubMed
37.
go back to reference Spickett CM, Jerlich A, Panasenko OM, Arnhold J, Pitt AR, Stelmaszynska T, Schaur RI: The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochem Pol. 2000, 47: 889-899. Spickett CM, Jerlich A, Panasenko OM, Arnhold J, Pitt AR, Stelmaszynska T, Schaur RI: The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochem Pol. 2000, 47: 889-899.
38.
go back to reference Bocci V: Is it true that ozone is always toxic? The end of the dogma. Toxicol Appl Pharmacol. 2006, 216: 493-504.PubMed Bocci V: Is it true that ozone is always toxic? The end of the dogma. Toxicol Appl Pharmacol. 2006, 216: 493-504.PubMed
39.
go back to reference Zhang W, He Q, Chan LL, Zhou F, El Naghy M, Thompson EB, Ansari NH: Involvement of caspases in 4-hydroxy-alkenal induced apoptosis in human leukemic cells. Free Radic Biol Med. 2001, 30: 699-706.PubMed Zhang W, He Q, Chan LL, Zhou F, El Naghy M, Thompson EB, Ansari NH: Involvement of caspases in 4-hydroxy-alkenal induced apoptosis in human leukemic cells. Free Radic Biol Med. 2001, 30: 699-706.PubMed
40.
go back to reference Choudhary S, Zhang W, Zhou F, Campbell GA, Chan LL, Thompson EB, Ansari NH: Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells. Free Radic Biol Med. 2002, 32: 360-369.PubMed Choudhary S, Zhang W, Zhou F, Campbell GA, Chan LL, Thompson EB, Ansari NH: Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells. Free Radic Biol Med. 2002, 32: 360-369.PubMed
41.
go back to reference Larini A, Bianchi L, Bocci V: Effect of 4-hydroxynonenal on antioxidant capacity and apoptosis induction in Jurkat T cells. Free Radic Res. 2004, 38: 509-516.PubMed Larini A, Bianchi L, Bocci V: Effect of 4-hydroxynonenal on antioxidant capacity and apoptosis induction in Jurkat T cells. Free Radic Res. 2004, 38: 509-516.PubMed
42.
go back to reference Awasthi YC, Ansari GA, Awasthi S: Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases. Methods Enzymol. 2005, 401: 379-407.PubMed Awasthi YC, Ansari GA, Awasthi S: Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases. Methods Enzymol. 2005, 401: 379-407.PubMed
43.
go back to reference Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ: HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic Biol Med. 2005, 39: 355-364.PubMedCentralPubMed Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ: HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic Biol Med. 2005, 39: 355-364.PubMedCentralPubMed
44.
go back to reference Barrera G, Pizzimenti S, Dianzani MU: 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway. Free Radic Biol Med. 2004, 37: 597-606.PubMed Barrera G, Pizzimenti S, Dianzani MU: 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway. Free Radic Biol Med. 2004, 37: 597-606.PubMed
45.
go back to reference Bocci V, Borrelli E, Valacchi G, Luzzi E: Quasi-total-body exposure to an oxygen-ozone mixture in a sauna cabin. Eur J Appl Physiol Occup Physiol. 1999, 80: 549-554.PubMed Bocci V, Borrelli E, Valacchi G, Luzzi E: Quasi-total-body exposure to an oxygen-ozone mixture in a sauna cabin. Eur J Appl Physiol Occup Physiol. 1999, 80: 549-554.PubMed
46.
go back to reference Bocci V: Ozone A new medical drug. 2011, Dordrecht, The Netherlands: Springer Publ, 2 Bocci V: Ozone A new medical drug. 2011, Dordrecht, The Netherlands: Springer Publ, 2
47.
go back to reference Poli G, Schaur RJ: 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life. 2000, 50: 315-321.PubMed Poli G, Schaur RJ: 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life. 2000, 50: 315-321.PubMed
48.
go back to reference Chiarpotto E, Castello L, Leonarduzzi G, Biasi A, Poli G: Role of 4-hydroxy-2,3-nonenal in the pathogenesis of fibrosis. BioFactors. 2005, 24: 229-236.PubMed Chiarpotto E, Castello L, Leonarduzzi G, Biasi A, Poli G: Role of 4-hydroxy-2,3-nonenal in the pathogenesis of fibrosis. BioFactors. 2005, 24: 229-236.PubMed
49.
go back to reference Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, Gerli R: Studies on the biological effects of ozone. 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents. 1998, 12: 67-75.PubMed Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, Gerli R: Studies on the biological effects of ozone. 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents. 1998, 12: 67-75.PubMed
50.
go back to reference Bocci V: Oxygen-ozone Therapy A Critical Evaluation. 2002, Dordrecht, The Netherlands, Kluwer Academic Publishers Bocci V: Oxygen-ozone Therapy A Critical Evaluation. 2002, Dordrecht, The Netherlands, Kluwer Academic Publishers
51.
go back to reference Stone JR, Collins T: The role of hydrogen peroxide in endothelial proliferative responses. Endothelium. 2002, 9: 231-238.PubMed Stone JR, Collins T: The role of hydrogen peroxide in endothelial proliferative responses. Endothelium. 2002, 9: 231-238.PubMed
52.
go back to reference Bocci V, Aldinucci C: The use of hydrogen peroxide as a medical drug. Riv Ital Ossigeno-Ozonoter. 2005, 4: 30-39. Bocci V, Aldinucci C: The use of hydrogen peroxide as a medical drug. Riv Ital Ossigeno-Ozonoter. 2005, 4: 30-39.
53.
go back to reference Goldstein BD, Balchum OJ: Effect of ozone on lipid peroxidation in the red blood cell. Proc Soc Exp Biol Med. 1967, 126: 356-359.PubMed Goldstein BD, Balchum OJ: Effect of ozone on lipid peroxidation in the red blood cell. Proc Soc Exp Biol Med. 1967, 126: 356-359.PubMed
54.
go back to reference Rice-Evans C, Miller NJ: Total antioxidant status in plasma and body fluids. Methods Enzymol. 1994, 234: 279-293.PubMed Rice-Evans C, Miller NJ: Total antioxidant status in plasma and body fluids. Methods Enzymol. 1994, 234: 279-293.PubMed
55.
go back to reference Travagli V, Zanardi I, Silvietti A, Bocci V: A physicochemical investigation on the effects of ozone on blood. Int J Biol Macromol. 2007, 41: 504-511.PubMed Travagli V, Zanardi I, Silvietti A, Bocci V: A physicochemical investigation on the effects of ozone on blood. Int J Biol Macromol. 2007, 41: 504-511.PubMed
56.
go back to reference Bocci V: Scientific and medical aspects of ozone therapy, State of the art. Arch Med Res. 2006, 37: 425-435.PubMed Bocci V: Scientific and medical aspects of ozone therapy, State of the art. Arch Med Res. 2006, 37: 425-435.PubMed
57.
go back to reference Bocci V: The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007, 64: 44-47.PubMed Bocci V: The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007, 64: 44-47.PubMed
58.
go back to reference Bocci V, Borrelli E, Travagli V, Zanardi I: The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Medicinal Res Rev. 2009, 29: 646-682. Bocci V, Borrelli E, Travagli V, Zanardi I: The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Medicinal Res Rev. 2009, 29: 646-682.
59.
go back to reference Bocci V, Borrelli E, Corradeschi F, Valacchi G: Systemic effects after colorectal insufflation of oxygen-ozone in rabbits. Int J Med Biol Environ. 2000, 28: 109-113. Bocci V, Borrelli E, Corradeschi F, Valacchi G: Systemic effects after colorectal insufflation of oxygen-ozone in rabbits. Int J Med Biol Environ. 2000, 28: 109-113.
60.
go back to reference Alary J, Geuraud F, Cravedi JP: Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol Aspects Med. 2003, 24: 177-187.PubMed Alary J, Geuraud F, Cravedi JP: Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol Aspects Med. 2003, 24: 177-187.PubMed
61.
go back to reference Siems W, Grune T: Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med. 2003, 24: 167-175.PubMed Siems W, Grune T: Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med. 2003, 24: 167-175.PubMed
62.
go back to reference Bocci V: Does ozone therapy normalize the cellular redox balance ?. Med Hypotheses. 1996, 46: 150-154.PubMed Bocci V: Does ozone therapy normalize the cellular redox balance ?. Med Hypotheses. 1996, 46: 150-154.PubMed
63.
go back to reference Zhang H, Liu H, Iles KE, Liu RM, Postlethwait EM, Laperche Y, Forman HI: 4-hydroxynonenal induces rat gamma-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/nuclear factor erythroid 2-related factor 2 signaling. Am J Respir Cell Mol Biol. 2006, 34: 174-181.PubMedCentralPubMed Zhang H, Liu H, Iles KE, Liu RM, Postlethwait EM, Laperche Y, Forman HI: 4-hydroxynonenal induces rat gamma-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/nuclear factor erythroid 2-related factor 2 signaling. Am J Respir Cell Mol Biol. 2006, 34: 174-181.PubMedCentralPubMed
64.
go back to reference Takahashi Y, Takahashi S, Yoshimi T, Miura T, Mochitate K, Kobayashi T: Increase in the mRNA levels of γ-glutamyl-transferase and heme-oxygenase-1 in the rat lung after ozone exposure. Biochem Pharmacol. 1997, 53: 1061-1064.PubMed Takahashi Y, Takahashi S, Yoshimi T, Miura T, Mochitate K, Kobayashi T: Increase in the mRNA levels of γ-glutamyl-transferase and heme-oxygenase-1 in the rat lung after ozone exposure. Biochem Pharmacol. 1997, 53: 1061-1064.PubMed
65.
go back to reference Chen JZ, Sharma R, Yang Y, Singhal SS, Sharma A, Saini MK, Singh SV, Zimniak P, Awasthi S, Awasthi YC: Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP 76 and hGST 5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem. 2001, 276: 41213-41223. Chen JZ, Sharma R, Yang Y, Singhal SS, Sharma A, Saini MK, Singh SV, Zimniak P, Awasthi S, Awasthi YC: Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP 76 and hGST 5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem. 2001, 276: 41213-41223.
66.
go back to reference Forman HJ, Dickinson DA, Iles KE: HNE-signaling pathways leading to its elimination. Mol Aspects Med. 2003, 24: 189-194.PubMed Forman HJ, Dickinson DA, Iles KE: HNE-signaling pathways leading to its elimination. Mol Aspects Med. 2003, 24: 189-194.PubMed
67.
go back to reference Yamamoto Y: Fate of lipid hydroperoxide in blood plasma. Free Radic Res. 2000, 33: 795-800.PubMed Yamamoto Y: Fate of lipid hydroperoxide in blood plasma. Free Radic Res. 2000, 33: 795-800.PubMed
68.
go back to reference Xu C, Huang MT, Shen G, Lin W, Khor TO, Conney AH, Kong AN: Inhibition of 7,12-dimethylbenzo(a) -anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res. 2006, 66: 8293-8296.PubMed Xu C, Huang MT, Shen G, Lin W, Khor TO, Conney AH, Kong AN: Inhibition of 7,12-dimethylbenzo(a) -anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res. 2006, 66: 8293-8296.PubMed
69.
go back to reference Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN: Activation of Nrf2-antioxidant signaling attenuates NF kappa B-inflammatory response and elicits apotosis. Biochem Pharmacol. 2008, 76: 1485-1489.PubMedCentralPubMed Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN: Activation of Nrf2-antioxidant signaling attenuates NF kappa B-inflammatory response and elicits apotosis. Biochem Pharmacol. 2008, 76: 1485-1489.PubMedCentralPubMed
70.
71.
go back to reference Gomez-Cabrera MC, Domenech E, Vina J: Moderate exercise is an antioxidant: Upregulation of antioxidant genes by traning. Free Radic Biol Med. 2008, 44: 126-131.PubMed Gomez-Cabrera MC, Domenech E, Vina J: Moderate exercise is an antioxidant: Upregulation of antioxidant genes by traning. Free Radic Biol Med. 2008, 44: 126-131.PubMed
72.
go back to reference Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y: An Nrf2/small Maf heterodimer mediate the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997, 236: 313-322.PubMed Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y: An Nrf2/small Maf heterodimer mediate the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997, 236: 313-322.PubMed
73.
go back to reference Motohashi H, Yamamoto M: Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004, 10: 549-557.PubMed Motohashi H, Yamamoto M: Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004, 10: 549-557.PubMed
74.
go back to reference Dinkova-Kostova AT: Phytochemicals as protectors against ultraviolet radiation: Versatility of effects and mechanisms. Planta Med. 2008, 74: 1548-1559.PubMed Dinkova-Kostova AT: Phytochemicals as protectors against ultraviolet radiation: Versatility of effects and mechanisms. Planta Med. 2008, 74: 1548-1559.PubMed
75.
go back to reference Brunt KB, Fenrich KK, Kiani G: Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol. 2006, 26: 2027-2034.PubMed Brunt KB, Fenrich KK, Kiani G: Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol. 2006, 26: 2027-2034.PubMed
76.
go back to reference He X, Lin GX, Chen MG, Zhang JX, Ma Q: Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap 1 association. Toxicol Sci. 2007, 98: 298-309.PubMed He X, Lin GX, Chen MG, Zhang JX, Ma Q: Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap 1 association. Toxicol Sci. 2007, 98: 298-309.PubMed
77.
go back to reference Khodagholi F, Tusi SK: Stability of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells. Mol Cell Biochem. 2011, 354: 97-112.PubMed Khodagholi F, Tusi SK: Stability of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells. Mol Cell Biochem. 2011, 354: 97-112.PubMed
78.
go back to reference Villeneuve NF, Sun Z, Chen W, Zhang DD: Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle. 2009, 8: 3255-3256.PubMedCentralPubMed Villeneuve NF, Sun Z, Chen W, Zhang DD: Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle. 2009, 8: 3255-3256.PubMedCentralPubMed
79.
go back to reference Slocum SL, Kensler TW: Nrf2: control of sensitivity to carcinogens. Arch Toxicol. 2011, 85: 272-284. Slocum SL, Kensler TW: Nrf2: control of sensitivity to carcinogens. Arch Toxicol. 2011, 85: 272-284.
80.
go back to reference Martin-Montalvo A, Villalba JM, Navas P, de Cabo R: NRF2, cancer and calorie restriction. Oncogene. 2011, 30: 505-520.PubMed Martin-Montalvo A, Villalba JM, Navas P, de Cabo R: NRF2, cancer and calorie restriction. Oncogene. 2011, 30: 505-520.PubMed
81.
go back to reference Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC: The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci. 2008, 1147: 61-69.PubMedCentralPubMed Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC: The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci. 2008, 1147: 61-69.PubMedCentralPubMed
82.
go back to reference Jazwa A, Cuadrado A: Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets. 2010, 11: 1517-1531.PubMed Jazwa A, Cuadrado A: Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets. 2010, 11: 1517-1531.PubMed
83.
go back to reference Bocci V, Travagli V, Zanardi I: May oxygen-ozone therapy improves cardiovascular disorders ?. Cardiovascular & Haematological Disorders-Drug Targets. 2009, 9: 78-85. Bocci V, Travagli V, Zanardi I: May oxygen-ozone therapy improves cardiovascular disorders ?. Cardiovascular & Haematological Disorders-Drug Targets. 2009, 9: 78-85.
84.
go back to reference Bocci V, Zanardi I, Travagli V: Ozone: a new medical drug in vascular diseases. Am J Cardiovas Drugs. 2011, 11: 73-82. Bocci V, Zanardi I, Travagli V: Ozone: a new medical drug in vascular diseases. Am J Cardiovas Drugs. 2011, 11: 73-82.
85.
go back to reference Li J, Ichikawa T, Janichi JS, Cui T: Targeting the Nrf2 pathway against cardiovascular disease. Expert Opin Ther Targets. 2009, 13: 785-794.PubMed Li J, Ichikawa T, Janichi JS, Cui T: Targeting the Nrf2 pathway against cardiovascular disease. Expert Opin Ther Targets. 2009, 13: 785-794.PubMed
86.
go back to reference Ishii Y, Morishima Y, Kimura T, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, Yamamoto M, Sekizawa K: Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol. 2005, 175: 6968-6975.PubMed Ishii Y, Morishima Y, Kimura T, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, Yamamoto M, Sekizawa K: Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol. 2005, 175: 6968-6975.PubMed
87.
go back to reference Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med. 2010, 49: 1603-1616.PubMedCentralPubMed Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med. 2010, 49: 1603-1616.PubMedCentralPubMed
88.
go back to reference Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P: Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory disease. Free Radic Res. 2010, 44: 1267-1288.PubMed Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P: Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory disease. Free Radic Res. 2010, 44: 1267-1288.PubMed
89.
90.
go back to reference Rokitansky O: Klinik und biochemie der ozonotherapie. Hospitalis. 1982, 52: 643-647. Rokitansky O: Klinik und biochemie der ozonotherapie. Hospitalis. 1982, 52: 643-647.
91.
go back to reference Bocci V, Larini A, Micheli V: Restoration of normoxia by ozonetherapy may control neoplastic growth: A review and a working hypothesis. J Altern Complem: Med. 2005, 11: 257-265. Bocci V, Larini A, Micheli V: Restoration of normoxia by ozonetherapy may control neoplastic growth: A review and a working hypothesis. J Altern Complem: Med. 2005, 11: 257-265.
92.
go back to reference Travagli V, Zanardi I, Bernini P, Nepi S, Tenori L, Bocci V: Effects of ozone blood treatment on the metabolite profile of human blood. Intern J Toxicol. 2010, 29: 165-174. Travagli V, Zanardi I, Bernini P, Nepi S, Tenori L, Bocci V: Effects of ozone blood treatment on the metabolite profile of human blood. Intern J Toxicol. 2010, 29: 165-174.
93.
go back to reference Bocci V, Di Paolo N: Oxygenation-ozonation of blood during extracorporeal circulation (EBOO). Part III: a new medical approach. Ozone Sci Eng. 2004, 26: 195-205. Bocci V, Di Paolo N: Oxygenation-ozonation of blood during extracorporeal circulation (EBOO). Part III: a new medical approach. Ozone Sci Eng. 2004, 26: 195-205.
94.
go back to reference Di Paolo N, Bocci V, Salvo DP, Palasciano G, Biagioli M, Meini S, Galli F, Ciari I, Maccari F, Cappelletti F, Di Paolo M, Gaggiotti E: Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. Int J Artif Organs. 2005, 28: 1039-1050.PubMed Di Paolo N, Bocci V, Salvo DP, Palasciano G, Biagioli M, Meini S, Galli F, Ciari I, Maccari F, Cappelletti F, Di Paolo M, Gaggiotti E: Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. Int J Artif Organs. 2005, 28: 1039-1050.PubMed
95.
go back to reference Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G: Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflamm. 2007, Article ID 26785 Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G: Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflamm. 2007, Article ID 26785
96.
go back to reference Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Pro Natl Acad Sci USA. 1995, 92: 5510-5514. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Pro Natl Acad Sci USA. 1995, 92: 5510-5514.
97.
go back to reference Siddiq A, Aminova LR, Ratan RR: Prolyl 4-hydroxylase activity-responsive transcription factors: From hydroxylation to gene expression and neuroprotection. Front Biosci. 2008, 13: 2875-2887.PubMedCentralPubMed Siddiq A, Aminova LR, Ratan RR: Prolyl 4-hydroxylase activity-responsive transcription factors: From hydroxylation to gene expression and neuroprotection. Front Biosci. 2008, 13: 2875-2887.PubMedCentralPubMed
98.
go back to reference Siddiq A, Aminova LR, Ratan RR: Hypoxia inducible factor prolyl 4-hydroxylase enzymes: Center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochem Res. 2007, 32: 931-946.PubMedCentralPubMed Siddiq A, Aminova LR, Ratan RR: Hypoxia inducible factor prolyl 4-hydroxylase enzymes: Center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochem Res. 2007, 32: 931-946.PubMedCentralPubMed
99.
go back to reference Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005, 105: 659-669.PubMed Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005, 105: 659-669.PubMed
100.
go back to reference Morsy MD, Hassan WN, Zalat SI: Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Diabeteol Metabol Syndr. 2010, 2: 29-35. Morsy MD, Hassan WN, Zalat SI: Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Diabeteol Metabol Syndr. 2010, 2: 29-35.
101.
go back to reference Martınez-Sanchez G, Al-Dalain SM, Menendez S, Re L, Giuliani A, Candelario-Jalil E, Alvarez H, Fernández-Montequín JI, León OS: Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005, 523: 151-161.PubMed Martınez-Sanchez G, Al-Dalain SM, Menendez S, Re L, Giuliani A, Candelario-Jalil E, Alvarez H, Fernández-Montequín JI, León OS: Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005, 523: 151-161.PubMed
102.
go back to reference Bocci V, Zanardi I, Michaeli V, Travagli V: Mechanisms of action and chemical-biological interactions between ozone and body compartments: a critical appraisal of the different administration routes. Current Drug Therapy. 2009, 4: 159-173. Bocci V, Zanardi I, Michaeli V, Travagli V: Mechanisms of action and chemical-biological interactions between ozone and body compartments: a critical appraisal of the different administration routes. Current Drug Therapy. 2009, 4: 159-173.
103.
go back to reference Eliakim R, Karmeli F, Rachmilewitz D: Ozone enema: a model of microscopic colitis in rats. Dig Dis Sci. 2001, 46: 2515-2520.PubMed Eliakim R, Karmeli F, Rachmilewitz D: Ozone enema: a model of microscopic colitis in rats. Dig Dis Sci. 2001, 46: 2515-2520.PubMed
104.
go back to reference Bocci V, Zanardi I, Huijberts MSP, Travagli V: Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabe Metabo Syndr: Clinical Research and Reviews. 2011, 5: 45-49. Bocci V, Zanardi I, Huijberts MSP, Travagli V: Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabe Metabo Syndr: Clinical Research and Reviews. 2011, 5: 45-49.
106.
go back to reference Amasaki Y: Calcineurin inhibitors and calcineurin-NFAT system. Nihon Rinsyo Meneki Gakkai Kaishi (Jpn J Clin Immunol). 2010, 33: 249- Amasaki Y: Calcineurin inhibitors and calcineurin-NFAT system. Nihon Rinsyo Meneki Gakkai Kaishi (Jpn J Clin Immunol). 2010, 33: 249-
107.
go back to reference Kaminuma O: Selective inhibitors of nuclear factor of activated T cells: potencial therapeutic drugs for the treatment of immunological and inflammatory diseases. Inflamm Allergy Drug Targets. 2008, 7: 35-40.PubMed Kaminuma O: Selective inhibitors of nuclear factor of activated T cells: potencial therapeutic drugs for the treatment of immunological and inflammatory diseases. Inflamm Allergy Drug Targets. 2008, 7: 35-40.PubMed
108.
go back to reference Maziere C, Morliere P, Louandre C, Conte MA, Gomilla C, Santus R, Antonicelli F, Hornebeck W, Mazière JC: Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcinurin pathway. Free Radic Biol Med. 2005, 39: 1629-1637.PubMed Maziere C, Morliere P, Louandre C, Conte MA, Gomilla C, Santus R, Antonicelli F, Hornebeck W, Mazière JC: Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcinurin pathway. Free Radic Biol Med. 2005, 39: 1629-1637.PubMed
109.
go back to reference Bocci V, Paulesu L: Studies on the biological effects of ozone 1. Induction of interferon gamma on human leukocytes. Haematologica. 1990, 75: 510-515.PubMed Bocci V, Paulesu L: Studies on the biological effects of ozone 1. Induction of interferon gamma on human leukocytes. Haematologica. 1990, 75: 510-515.PubMed
110.
go back to reference Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A: Studies on the biological effects of ozone 4. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 1993, 12: 121-126.PubMed Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A: Studies on the biological effects of ozone 4. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 1993, 12: 121-126.PubMed
111.
go back to reference Bocci V, Valacchi G, Corradeschi F, Fanetti G: Studies on the biological effects of ozone 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators Inflamm. 1998, 7: 313-317.PubMedCentralPubMed Bocci V, Valacchi G, Corradeschi F, Fanetti G: Studies on the biological effects of ozone 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators Inflamm. 1998, 7: 313-317.PubMedCentralPubMed
112.
go back to reference Bocci VA, Zanardi I, Travagli V: Ozone acting on human blood yields a hormetic dose-response relationship. J Translational Medicine. 2011, 9: 66-76. Bocci VA, Zanardi I, Travagli V: Ozone acting on human blood yields a hormetic dose-response relationship. J Translational Medicine. 2011, 9: 66-76.
113.
go back to reference Burgassi S, Zanardi I, Travagli V, Montomoli E, Bocci V: How much ozone bactericidal activity is compromised by plasma components ?. J.Appl Microbiol. 2009, 106: 1715-1721.PubMed Burgassi S, Zanardi I, Travagli V, Montomoli E, Bocci V: How much ozone bactericidal activity is compromised by plasma components ?. J.Appl Microbiol. 2009, 106: 1715-1721.PubMed
114.
go back to reference Bocci V, Venturi G, Catucci M, Valensin PE, Zazzi M: Lack of efficacy of ozone therapy in HIV infection. Clin Microbiol Infec. 1998, 4: 667-669. Bocci V, Venturi G, Catucci M, Valensin PE, Zazzi M: Lack of efficacy of ozone therapy in HIV infection. Clin Microbiol Infec. 1998, 4: 667-669.
115.
go back to reference Sweet F, Kao MS, Lee S: Ozone selectively inhibits growth of human cancer cells. Science. 1980, 209: 931-933.PubMed Sweet F, Kao MS, Lee S: Ozone selectively inhibits growth of human cancer cells. Science. 1980, 209: 931-933.PubMed
116.
go back to reference Schulz S, Haussler U, Mandic R, Heverhagen JT, Neubauer A, Dünne AA, Werner JA, Weihe E, Bette M: Treatment with ozone/oxygen-pneumoperitoneum results in complete remmision of rabbit squamous cell carcinomas. Int J Cancer. 2008, 122: 2360-2367.PubMed Schulz S, Haussler U, Mandic R, Heverhagen JT, Neubauer A, Dünne AA, Werner JA, Weihe E, Bette M: Treatment with ozone/oxygen-pneumoperitoneum results in complete remmision of rabbit squamous cell carcinomas. Int J Cancer. 2008, 122: 2360-2367.PubMed
117.
go back to reference Bocci V: Does ozone really "cure" cancer ?. Int J Cancer. 2008, 123: 1222-PubMed Bocci V: Does ozone really "cure" cancer ?. Int J Cancer. 2008, 123: 1222-PubMed
118.
119.
go back to reference Tufekci KU, Civi Bathway E, Genc S, Genc K: The Nrf2/ARE pathway: A promising target to counteract mitochondrial dysfunction in Parkinson's disease. 2011, Parkinson's disease, Tufekci KU, Civi Bathway E, Genc S, Genc K: The Nrf2/ARE pathway: A promising target to counteract mitochondrial dysfunction in Parkinson's disease. 2011, Parkinson's disease,
120.
go back to reference Idriss NK, Blann AD, Lip GY: Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008, 52: 971-978.PubMed Idriss NK, Blann AD, Lip GY: Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008, 52: 971-978.PubMed
121.
go back to reference Scapagnini G, Sonya V, Nader AG, Zella D, Fabio G: Modulation of Nrf2/ARE pathway by food polyphenols: A nutritional neuroprotective strategy for cognitive and neurodegerative disorders. Mol Neurobiol. 2011, Scapagnini G, Sonya V, Nader AG, Zella D, Fabio G: Modulation of Nrf2/ARE pathway by food polyphenols: A nutritional neuroprotective strategy for cognitive and neurodegerative disorders. Mol Neurobiol. 2011,
122.
go back to reference Kweon MH, Adhami VM, Lee JS, Mukhtar H: Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A459 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem. 2006, 44: 33761-33772. Kweon MH, Adhami VM, Lee JS, Mukhtar H: Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A459 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem. 2006, 44: 33761-33772.
123.
go back to reference Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, Liby KT, Risingsong R, Sporn M, Beal MF, Kiaei M: Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethlamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med. 2011, 51: 88-96.PubMedCentralPubMed Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, Liby KT, Risingsong R, Sporn M, Beal MF, Kiaei M: Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethlamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med. 2011, 51: 88-96.PubMedCentralPubMed
124.
go back to reference Son TG, Camandola S, Mattson MP: Hormetic dietary phytochemicals. Neuromolecul Med. 2008, 10: 236-46. Son TG, Camandola S, Mattson MP: Hormetic dietary phytochemicals. Neuromolecul Med. 2008, 10: 236-46.
125.
go back to reference Miura T, Iwai A, Tamoto K, Yamazaki A, Nochi H: Components and ant-inflammatory action mechanism of ozonized olive oil. In Proceeding of 19th Ozone World Congress of the IOA: Aug31-Sep3 2009; Tokyo, 145-166. Miura T, Iwai A, Tamoto K, Yamazaki A, Nochi H: Components and ant-inflammatory action mechanism of ozonized olive oil. In Proceeding of 19th Ozone World Congress of the IOA: Aug31-Sep3 2009; Tokyo, 145-166.
126.
go back to reference Valacchi G, Lim Y, Belmonte G, Miracco C, Zanardi I, Bocci V, Travagli V: Ozonated sesame oil enhances cutaneous wound healing in SKH1 mice. Wound Reapir Regener. 2010, 19: 107-115. Valacchi G, Lim Y, Belmonte G, Miracco C, Zanardi I, Bocci V, Travagli V: Ozonated sesame oil enhances cutaneous wound healing in SKH1 mice. Wound Reapir Regener. 2010, 19: 107-115.
127.
go back to reference Travagli V, Zanardi I, Bocci V: Topical application of ozone and ozonated oils as anti-infective agents: an insight into the patent claims. Recent Patents on Anti-Infective Drug Discovery. 2009, 4: 130-142.PubMed Travagli V, Zanardi I, Bocci V: Topical application of ozone and ozonated oils as anti-infective agents: an insight into the patent claims. Recent Patents on Anti-Infective Drug Discovery. 2009, 4: 130-142.PubMed
128.
go back to reference Travagli V, Zanardi I, Valacchi G, Bocci V: Ozone and ozonated oils in skin diseases: a review. Mediators Inflamm. 2010, (2010 Article ID 610418, EPUB 2010) July 4, Review Travagli V, Zanardi I, Valacchi G, Bocci V: Ozone and ozonated oils in skin diseases: a review. Mediators Inflamm. 2010, (2010 Article ID 610418, EPUB 2010) July 4, Review
129.
go back to reference Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R, Leonardi M: Minimally invasive oxygen-ozone therapy for lumbar disk herniation. Am J Neuroradiol. 2003, 24: 996-1000.PubMed Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R, Leonardi M: Minimally invasive oxygen-ozone therapy for lumbar disk herniation. Am J Neuroradiol. 2003, 24: 996-1000.PubMed
130.
go back to reference Bocci V, Pogni R, Corradeschi F, Busu E, Cervelli C, Bocchi L, Basosi R: Oxygen-ozone in orthopaedics: EPR detection of hydroxyl free radicals in ozone-treated "nucleus pulposus" material. Riv Neuroradiol. 2001, 14: 55-59. Bocci V, Pogni R, Corradeschi F, Busu E, Cervelli C, Bocchi L, Basosi R: Oxygen-ozone in orthopaedics: EPR detection of hydroxyl free radicals in ozone-treated "nucleus pulposus" material. Riv Neuroradiol. 2001, 14: 55-59.
131.
go back to reference Bocci V, Bianchi L, Larini A: The ozone enigma in medicine. The biochemical relationship between ozone and body fluids may account for its biological, therapeutic and toxic effects. Riv Ital Ossigeno-Ozonoterapia. 2003, 2: 113-120. Bocci V, Bianchi L, Larini A: The ozone enigma in medicine. The biochemical relationship between ozone and body fluids may account for its biological, therapeutic and toxic effects. Riv Ital Ossigeno-Ozonoterapia. 2003, 2: 113-120.
132.
go back to reference Lynch E: Ozone: The Revolution in Dentistry. 2004, Copenhagen, Quintessence books Lynch E: Ozone: The Revolution in Dentistry. 2004, Copenhagen, Quintessence books
133.
go back to reference Chandiramani N, Wang X, Margeta M: Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CR1-G1 cell line. PloS One. 2011, 6: in press Chandiramani N, Wang X, Margeta M: Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CR1-G1 cell line. PloS One. 2011, 6: in press
134.
go back to reference Bocci V, Zanardi I, Travagli V: Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Medical Gas Research. 2011, 1: 6-PubMedCentralPubMed Bocci V, Zanardi I, Travagli V: Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Medical Gas Research. 2011, 1: 6-PubMedCentralPubMed
135.
go back to reference Jacobs MT: Untersuchung uber Zwischendalle und typische Komplikationen in der ozon-Sauersoff - Therapie. OzoNachrichten. 1982, 1: 5- Jacobs MT: Untersuchung uber Zwischendalle und typische Komplikationen in der ozon-Sauersoff - Therapie. OzoNachrichten. 1982, 1: 5-
136.
go back to reference Bocci V, Zanardi I, Travagli V: Potentiality of oxygen-ozone therapy to improve the health of aging people. Curr Aging Sci. 2010, 3: 177-187.PubMed Bocci V, Zanardi I, Travagli V: Potentiality of oxygen-ozone therapy to improve the health of aging people. Curr Aging Sci. 2010, 3: 177-187.PubMed
Metadata
Title
Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?
Authors
Masaru Sagai
Velio Bocci
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Medical Gas Research / Issue 1/2011
Electronic ISSN: 2045-9912
DOI
https://doi.org/10.1186/2045-9912-1-29

Other articles of this Issue 1/2011

Medical Gas Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.